facebook linked in twitter youtube instagram

Nelson Mullins COVID-19 Resources

Nelson Mullins is continuing to monitor developments related to COVID-19, including guidance from the Centers for Disease Control and various federal, state, and local government authorities. The firm is taking appropriate precautionary actions and has implemented plans to ensure the continuation of all firm services to clients from both in office and remote work arrangements across our 25 offices. 

In addition, click the link below to access extensive resources to address a wide variety of topics resulting from the virus, in general and by industry,  including topics such as essential businesses, force majeure, business interruption insurance, CARES Act and FFCRA, and others. 

Nelson Mullins COVID-19 Resources

The LatestView All

How the COVID-19 Pandemic Impacts Pennsylvania Tax Lien Sales

October 12, 2020

How the COVID-19 Pandemic Impacts Pennsylvania Tax Lien Sales


Sept. 29, 2020

Recent Developments in Artificial Intelligence and the Accompanying Liability Risks

By Joseph E. Fornadel, III, Wesley T. Moran

Imaging Technology News; Diagnostic and Interventional Cardiology

As the FDA continues to clear AI-based algorithms at a steady pace, the medical field has become increasingly aware of the boundless gains in efficiency and access to care offered by artificial intelligence innovations. In articles for Imaging Technology News and Diagnostic and Interventional Cardiology, associates Joe Fornadel and Wes Moran outline the expected benefits of AI for physicians and patients, while discussing potential liabilities as the courts have yet to grapple with medical AI.

The article notes that, as AI evolves, it has the potential to perform better than even the most skilled and knowledgeable physicians in certain fields. Benefits of medical AI innovation may include increased efficiency in treating and/or diagnosing patients by giving physicians the ability to focus on diagnoses and procedures that require greater skill and judgment; increased diagnostic accuracy; earlier detection of disease; improved treatment regimens; and lower healthcare risks. However, the authors add that there are several risks associated with integrating AI into medical devices used to diagnose and treat patients.

Fornadel and Moran write, “The use of AI is likely going to change the liability landscape,” describing considerations around potential liability for harm to patients, the unauthorized use of protected healthcare and HIPAA violations, and the potential for reduced physician and patient medical decision making.

To read their insights and the full articles, please visit Imaging Technology News here and Diagnostic and Interventional Cardiology here.